| |
| |
|
| Insider
Information: |
Mahoney Michael F |
| Relationship: |
Director |
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
1,694,743 |
|
|
Indirect Shares
|
196,852 |
|
|
| Direct
Value |
$125,826,969 |
|
|
|
Indirect Value
|
$13,985,993 |
|
|
| Total
Shares |
1,891,595 |
|
|
| Total
Value |
$139,812,963 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 1.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
Chairman, President & ... |
2024-02-18 |
1,673,878 |
2024-02-18 |
176,245 |
Premium* |
|
|
Baxter International Inc |
BAX |
Director |
2023-05-02 |
9,692 |
2023-05-02 |
20,397 |
Premium* |
|
|
CVS/Caremark Corp |
CVS |
Director |
2024-05-02 |
11,173 |
2024-05-02 |
210 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
189 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2017-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,744 |
2,013,705 |
0 |
- |
|
| BAX |
Baxter International Inc |
Director |
– • – |
2017-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,616 |
5,784 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
129,246 |
1,982,386 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
237,584 |
2,164,800 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,175 |
2,082,368 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,758 |
2,095,824 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,052 |
2,114,315 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
69,074 |
2,170,475 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-11-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
31,800 |
1,757,972 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2019-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
132,328 |
1,890,300 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2019-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,456 |
1,853,998 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2019-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
231,748 |
2,077,542 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2019-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,175 |
1,997,705 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2019-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,759 |
2,011,162 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2019-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,052 |
2,029,653 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2019-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,330 |
2,035,069 |
0 |
- |
|
| BAX |
Baxter International Inc |
Director |
– • – |
2019-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,206 |
3,898 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2020-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
89,449 |
2,116,370 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
151,220 |
2,231,042 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2020-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,457 |
2,182,357 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2020-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,824 |
2,190,986 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2020-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,175 |
2,206,691 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2020-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,759 |
2,220,160 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2020-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,330 |
2,227,941 |
0 |
- |
|
| BAX |
Baxter International Inc |
Director |
– • – |
2020-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,099 |
1,137 |
0 |
- |
|
189 Records found
|
|
Page 2 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
